SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For Quarter Ended June 30, 1998 Commission File Number 1-922
THE GILLETTE COMPANY
(Exact name of registrant as specified in its charter)
Incorporated in Delaware 04-1366970
(State or other jurisdiction of (IRS Employer Identification No.)
incorporation or organization)
Prudential Tower Building, Boston, Massachusetts 02199
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (617) 421-7000
Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15 (d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period
that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.
Yes X No
Indicate the number of shares outstanding of each of the issuer's classes
of common stock, as of the latest practicable date.
Title of each class
Common Stock, $1.00 par value
Shares Outstanding June 30, 1998 . . . . . . . . . . . . . . . 1,122,903,301
<PAGE>
<TABLE>
PAGE 1
PART I. FINANCIAL INFORMATION
THE GILLETTE COMPANY AND SUBSIDIARY COMPANIES
CONSOLIDATED STATEMENT OF INCOME
(Millions, except per share amounts)
(Unaudited)
<CAPTION>
Three Months Ended Six Months Ended
June 30 June 30
1998 1997 1998 1997
<S> <C> <C> <C> <C>
Net Sales........................................ $2,325 $2,366 $4,350 $4,365
Cost of Sales.................................... 882 923 1,665 1,673
Gross Profit................................. 1,443 1,443 2,685 2,692
Selling, General and Administrative expenses..... 848 894 1,656 1,755
Profit from Operations....................... 595 549 1,029 937
Non-operating Charges (Income):
Interest income................................ (2) (3) (3) (5)
Interest expense............................... 17 20 34 38
Exchange....................................... 7 4 13 4
Other charges - net............................ (2) 5 (4) 10
20 26 40 47
Income before Income Taxes .................. 575 523 989 890
Income Taxes..................................... 203 187 349 318
Net Income................................... 372 336 640 572
Net Income per Common Share, basic .............. $ .33 $ .30 $ .57 $ .51
Net Income per Common Share, assuming full dilution $ .33 $ .29 $ .56 $ .50
Dividends declared per common share ............. $.1275 $.1075 $.1275 $.1075
Weighted average number of common shares outstanding
Basic ....................................... 1,124 1,117 1,123 1,115
Assuming full dilution....................... 1,154 1,148 1,153 1,147
<FN>
See Accompanying Notes to Consolidated Financial Statements.
</TABLE>
<PAGE>
<TABLE>
PAGE 2
THE GILLETTE COMPANY AND SUBSIDIARY COMPANIES
CONSOLIDATED BALANCE SHEET
ASSETS
(Millions of dollars)
<CAPTION>
June 30 December 31
1998 1997
(Unaudited)
<S> <C> <C>
Current Assets:
Cash and cash equivalents.................... $ 76 $ 105
Receivables, less allowances of $56
($74 at 12/31/97)....................... 2,362 2,522
Inventories:
Raw materials and supplies.............. 315 279
Work in process......................... 249 186
Finished goods.......................... 1,259 1,035
Total Inventories..................... 1,823 1,500
Deferred Income Taxes........................ 278 320
Prepaid expenses............................. 291 243
Total Current Assets................... 4,830 4,690
Property, Plant and Equipment, at cost........ 5,428 5,191
Less accumulated depreciation............ 2,217 2,087
Net Property, Plant and Equipment...... 3,211 3,104
Intangible Assets, less accumulated amortization 2,383 2,423
of Other Assets................................. 657 647
$11,081 $10,864
<FN>
See Accompanying Notes to Consolidated Financial Statements
</TABLE>
<PAGE>
<TABLE>
PAGE 3
THE GILLETTE COMPANY AND SUBSIDIARY COMPANIES
CONSOLIDATED BALANCE SHEET
LIABILITIES AND STOCKHOLDERS' EQUITY
(Millions of dollars)
<CAPTION>
June 30 December 31
1998 1997
(Unaudited)
<S> <C> <C>
Current Liabilities:
Loans payable................................ $ 668 $ 552
Current portion of long-term debt............ 9 9
Accounts payable............................. 502 542
Accrued liabilities.......................... 913 1,132
Dividends payable............................ - 120
Income taxes................................. 298 286
Total Current Liabilities................. 2,390 2,641
Long-Term Debt................................... 1,760 1,476
Deferred Income Taxes............................ 325 359
Other Long-Term Liabilities...................... 848 1,101
Minority Interest................................ 39 39
Contingent redemption value of common stock
put options.................................... 406 407
Stockholders' Equity:
8.0% Cumulative Series C ESOP Convertible
Preferred, without par value, issued: 1998,
151,501 shares; 1997, 154,156 shares....... 91 93
Unearned ESOP Compensation................... (14) (17)
Common stock, par value $1.00 per share:
Authorized 2,320,000,000 shares
Issued: 1998, 1,356,334,058 shares;
1997, 1,352,581,842 shares......... 1,356 1,353
Additional paid-in capital................... 386 309
Earnings reinvested in the business.......... 5,516 5,021
Currency translation and pension adjustments. (799) (810)
Treasury stock, at cost:
1998, 233,430,757 shares;l997, 231,643,130 shares(1,223) (1,108)
Total Stockholders' Equity............... 5,313 4,841
$11,081 $10,864
<FN>
See Accompanying Notes to Consolidated Financial Statements
</TABLE>
<PAGE>
<TABLE>
PAGE 4
THE GILLETTE COMPANY AND SUBSIDIARY COMPANIES
CONSOLIDATED STATEMENT OF CASH FLOWS
(Millions of dollars)
(Unaudited)
<CAPTION>
Six Months Ended
June 30
1998 1997
<S> <C>
<C>
Operating Activities
Net income $ 640 $ 572
Adjustments to reconcile net income to net
cash provided by operating activities:
Depreciation and amortization 232 207
Other (26) 13
Changes in assets and liabilities, net of
effects from acquisition of businesses:
Accounts receivable 117 511
Inventories (376) (303)
Accounts payable and accrued liabilities (233) (571)
Other working capital items (21) 57
Other non-current assets and liabilities (52) (18)
Net cash provided by operating activities 281 468
Investing Activities
Additions to property, plant & equipment (412) (379)
Disposals of property, plant & equipment 37 28
Sale of Business 200 -
Other 16 (2)
Net cash used in investing activities (159) (353)
Financing Activities
Purchase of Treasury Stock (116) -
Proceeds from sale of put options 23 -
Proceeds from exercise of stock option and
purchase plans 53 102
Funding German Pension Plans (252) -
Increase in long-term debt 288 -
Increase in loans payable 119 17
Dividends paid (266) (223)
Net cash used in financing activities (151) (104)
Effect of Exchange Rate Changes on Cash - (1)
Increase(decrease) in Cash and Cash Equivalents (29) 10
Cash and Cash Equivalents at Beginning of Year 105 84
Cash and Cash Equivalents at End of Quarter $ 76 $ 94
Supplemental disclosure of cash paid for:
Interest $ 53 $ 47
Income taxes $ 241 $ 228
<FN>
See Accompanying Notes to Consolidated Financial Statements
</TABLE>
<PAGE>
<TABLE>
PAGE 5
THE GILLETTE COMPANY AND SUBSIDIARY COMPANIES
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
(Millions of dollars)
(Unaudited)
<CAPTION>
Three Months Ended Six Months Ended
June 30 June 30
1998 1997 1998 1997
<S> <C> <C> <C> <C>
Net Income $372 $336 $640 $572
Other Comprehensive Income, net of tax:
Foreign Currency Translation Adj. (13) (58) 11 (86)
Comprehensive Income $359 $278 $651 $486
Foreign currency translation adjustments are after favorable(unfavorable)
tax effects for three months of $(2) million in 1998 and $(19) million in
1997 and for six months of $1 million in 1998 and $(31) million in 1997.
Other Comprehensive Income
The accumulated balances for the components of Other Comprehensive Income
are:
Minimum
Accumulated
Foreign Pension Other
Currency Liability Comprehensive
Translation Adjustment Income
Balance December 31, 1996 $(522) $ (20) $(542)
Change in period (28) - (28)
Balance March 31, 1997 (550) (20) (570)
Change in period (58) - (58)
Balance June 30, 1997 $(608) $ (20) $(628)
Balance December 31, 1997 $(790) $ (20) $(810)
Change in period 24 - 24
Balance March 31, 1998 (766) (20) (786)
Change in period (13) - (13)
Balance June 30, 1998 $(779) $ (20) $(799)
<FN>
See Accompanying Notes to Consolidated Financial Statements
</TABLE>
<PAGE>
PAGE 6
<TABLE>
THE GILLETTE COMPANY AND SUBSIDIARY COMPANIES
COMPUTATION OF NET INCOME PER COMMON SHARE
(Millions of dollars, except per share amounts; shares in millions)
(Unaudited)
<CAPTION>
Three Months Ended Six Months Ended
June 30 June 30
1998 1997 1998 1997
<S> <C> <C> <C> <C>
Net Income as reported....................... $ 372 $ 336 $ 640 $ 572
Less: Preferred stock dividends............. 1 1 2 2
Net Income, basic............................ $ 371 $ 335 $ 638 $ 570
Effect of dilutive securities:
Convertible preferred stock.............. 2 1 3 2
Net Income, assuming full dilution........... $ 373 $ 336 $ 641 $ 572
Common shares, basic......................... 1,124 1,117 1,123 1,115
Effect of dilutive securities:
Convertible preferred stock.............. 12 13 12 13
Stock options 18 18 18 19
Common shares, assuming full dilution........ 1,154 1,148 1,153 1,147
Net Income per Common Share
Basic...................................... $ .33 $ .30 $ .57 $ .51
Assuming full dilution..................... $ .33 $ .29 $ .56 $ .50
<FN> See Accompanying Notes to Consolidated Financial Statements
</TABLE>
<PAGE> PAGE 7
THE GILLETTE COMPANY AND SUBSIDIARY COMPANIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Accounting Comments
Reference is made to the registrant's 1997 annual report to stockholders,
which contains, at pages 26 through 41, financial statements and the notes
thereto, which are incorporated by reference in the registrant's annual
report on Form 10-K for the year ended December 31, 1997.
For interim reporting purposes, advertising expenses are charged to
operations as a percentage of sales based on estimated sales and
advertising expense for the full year.
Results for the first six months of 1997 have been recast, to reflect the
harmonization of operating groups on a common calendar quarter basis, in
the Consolidated Statements of Income and Cash Flows to provide
comparability to 1998 results. The Consolidated Balance Sheet as of
December 31, 1997, is as previously reported. The components of Other
Comprehensive Income for interim periods remain as previously reported.
At the Annual Meeting on April 16, 1998, the stockholders approved an
increase in the authorized common stock, $1 par value, to 2.32 billion
shares from 1.16 billion shares. Accordingly, a two-for-one stock split,
in the form of a 100% common stock dividend, was effective for
stockholders of record on
May 15, 1998. All share information has been restated to give effect to
the stock split.
With respect to the financial information for the interim periods included
in this report, which is unaudited, the management of the Company believes
that all adjustments necessary for a fair presentation of the results for
such interim periods have been included.
Accounting Pronouncements
In February, 1998, the Financial Accounting Standards Board issued SFAS
No. 132, "Employers' Disclosure about Pensions and Other Postretirement
Benefits," which revises employers' disclosures about pension and other
postretirement benefit plans. It does not change the measurement or
recognition of those plans. The statement is effective for fiscal years
beginning after December 15, 1997. The adoption of this statement has no
impact on the consolidated financial statements.
In March, 1998, the American Institute of Certified Public Accountants
issued Statement of Position 98-1 ("SOP 98-1"), "Accounting for the Costs
of Computer Software Developed or Obtained for Internal Use." The
statement is effective for fiscal years beginning after December 15, 1998.
Earlier application is encouraged in fiscal years for which annual
financial statements have not been issued. The statement defines which
costs of computer software developed or obtained for internal use are
capital and which costs are expensed. The Company adopted SOP 98-1
effective January 1st, 1998. The adoption of SOP 98-1 does not materially
affect the consolidated financial statements.
<PAGE> PAGE 8
THE GILLETTE COMPANY AND SUBSIDIARY COMPANIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
In April, 1998, the American Institute of Certified Public Accountants
issued Statement of Position 98-5 ("SOP 98-5"), "Reporting on the Costs of
Start-Up Activities." The statement is effective for fiscal years
beginning after December 15, 1998. The statement requires costs of start-
up activities and organization costs to be expensed as incurred. The
Company will adopt SOP 98-5 for calendar year 1999. The adoption of SOP
98-5 will not materially affect the consolidated financial statements.
In June, 1998, the Financial Accounting Standards Board issued SFAS
No.133, "Accounting for Derivative Instruments and Hedging Activities."
The statement requires companies to recognize all derivatives as either
assets or liabilities, with the instruments measured at fair value. The
accounting for changes in fair value, gains or losses, depends on the
intended use of the derivative and its resulting designation. The
statement is effective for all fiscal quarters of fiscal years beginning
after June 15, 1999. The Company will adopt SFAS 133 by January 1, 2000.
Adoption of SFAS 133 is not expected to have a material impact on the
consolidated financial statements.
Merger Related Costs
In conjunction with the 1996 merger with Duracell International Inc., the
Company recorded, in the fourth quarter of 1996, a charge to operating
expenses of $413 million. Restructuring activities, which will be
substantially complete at the end of 1998, primarily relate to the
consolidation of distribution and administrative functions, which will
result in the phased reduction of approximately 1,700 employees. Through
June 30, 1998, the reductions total 1,294 employees.
Activity through June 30, 1998 follows:
1996 Charges
(Millions of dollars) Provision to Date Balance
Merger Transaction Costs $ 65 $ 61 $ 4
Restructuring Costs
Employee Severance 166 104 62
Exit Costs 182 163 19
Total $ 413 $328 $ 85
Share Repurchase Program
During the second quarter of 1998 the Company repurchased 2 million shares
of common stock, under the Company's authorized 1997 share repurchase
program, at a cost of $116 million. Since the inception of the program in
late 1997, 3 million shares have been repurchased. During 1998 the
Company continues to sell written put options to enhance the ongoing share
repurchase program.
<PAGE> PAGE 9
THE GILLETTE COMPANY AND SUBSIDIARY COMPANIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Financial Information by Business Segment
Net sales, profit from operations and identifiable assets for each
of the Company's business segments are set forth below.
________________Net Sales_________________
Three Months Ended _Six Months Ended__
_____June 30_____ ______June 30______
(Millions of dollars) 1998 1997 1998 1997
Blades & Razors $ 742 $ 707 $1,326 $1,326
Toiletries 300 363 606 671
Stationery Products 218 227 384 415
Braun Products 344 355 687 684
Oral-B Products 157 154 301 293
Duracell Products 564 560 1,046 976
Other/Corporate --- --- --- ---
Total $2,325 $2,366 $4,350 $4,365
__________Profit from Operations__________
Three Months Ended _Six Months Ended__
_____June 30_____ ______June 30______
(Millions of dollars) 1998 1997 1998 1997
Blades & Razors $ 296 $ 294 $ 539 $ 555
Toiletries 28 43 51 76
Stationery Products 34 38 47 67
Braun Products 59 43 98 71
Oral-B Products 28 18 47 32
Duracell Products 130 121 228 158
Other/Corporate 20 (8) 19 (22)
Total $ 595 $ 549 $1,029 $ 937
Identifiable Assets
June 30 Mar 31 Dec 31 June 30 Mar 31 Dec 31
(Millions of dollars) 1998 1998 1997 1997 1997 1996
Blades & Razors $ 3,189 $ 3,009 $ 3,006 $ 2,639 $ 2,437 $ 2,591
Toiletries 794 861 1,004 944 887 874
Stationery Products 1,282 1,269 1,299 1,235 1,218 1,244
Braun Products 1,472 1,397 1,544 1,288 1,474 1,534
Oral-B Products 611 602 622 558 560 595
Duracell Products 3,017 2,926 3,138 3,030 2,932 3,154
Other/Corporate 716 628 251 514 545 423
Total $11,081 $10,692 $10,864 $10,208 $10,053 $10,415
<PAGE>
PAGE 10
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS
Results of Operations
In reviewing the following analysis, it should be understood that results
for any interim period are not necessarily indicative of the results for
the entire year.
Second Quarter 1998 versus 1997
Sales for the quarter ended June 30, 1998, were $2.33 billion, a decrease
of 2% over the same quarter of the prior year. Excluding unfavorable
exchange and the divestiture of Jafra Cosmetics International, sales
growth was 4%, primarily attributable to new products and pricing. Sales
of domestic operations were above those of the prior year. Sales in our
international operations were below the prior year, although excluding
unfavorable exchange, sales matched the prior year. Sales in Western
Europe were virtually unchanged versus the prior year, despite unfavorable
exchange. Sales in Latin America were somewhat below 1997 due to trade
destocking in Brazil, while sales in other international markets were
markedly below the prior year, due primarily to the continuing Asian
financial crisis.
Sales of blade and razor products were somewhat above prior year, buoyed
by significant sales gains in the United States, as a result of the first
week of Gillette MACH3 shipments at quarter end. International sales were
down marginally, due to unfavorable exchange in Europe and the Asian
financial crisis. Profits were virtually unchanged versus the prior year.
In the United States, profit growth was less than sales growth due to
costs related to the start-up of Gillette MACH3 and a heavy razor mix in
the initial MACH3 shipments. International profits were somewhat below
prior year.
Sales of Duracell products were about the same as prior year. The launch
of Duracell Ultra and price increases led to sales gains in the United
States and Western Europe. However, the gains were offset by significant
declines in Asia Pacific. Profits advanced versus prior year as the
United States and Western Europe improved their margins, on top of the
sales gains.
Braun sales were marginally below 1997 as significant growth in the United
States was offset by the strong dollar and weak business environment in
Japan. Profits were markedly above prior year, particularly in the United
States and Western Europe, the result of aggressive cost-reduction
activities.
Toiletries sales and profits were substantially below prior year, the
result of unmatched Jafra sales and profits since the divestiture on April
30, 1998. Excluding Jafra, toiletries sales were well below the prior
year, and profits dropped sharply, due to promotional timing of higher
margin deodorant and anti-perspirant brands, and continued softness in
White Rain.
Sales of stationery products were somewhat below 1997, as a considerable
sales increase in North America was more than offset by significantly
lower sales in Asia Pacific. Profits were considerably lower, the result
of significant declines in Asia Pacific and unmatched favorables in the
prior year.
<PAGE>
PAGE 11
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS
Sales of Oral-B products in the second quarter were modestly ahead of
prior year, led by strong volume growth of Advantage Control Grip in the
United States. Profits were up significantly, due to improved product mix
and lower overhead spending, with all geographic areas contributing strong
profit growth.
Six Months 1998 versus 1997
Sales for the six months ended June 30, 1998, were $4.35 billion,
virtually unchanged from 1997. Excluding unfavorable exchange and the
divestiture of Jafra Cosmetics International, sales growth was 5%,
attributable to new products, pricing and volume. Sales of domestic
operations were moderately above prior year. Sales in international
operations were slightly below prior year, although excluding unfavorable
exchange, sales were moderately above the prior year. Sales in Western
Europe were somewhat above the prior year, despite unfavorable exchange.
Sales in Latin America were about the same as prior year as trade
destocking in Brazil offset gains in other markets in Latin America.
Sales in other international markets were notably below the prior year due
to the continuing Asian financial crisis.
Sales of blade and razor products were unchanged versus those of the prior
year and profits were somewhat lower due to costs related to the start-up
of Gillette MACH3. Very good sales gains in the United States, driven by
Gillette MACH3, were offset by marginally lower international results,
primarily due to the Asian financial crisis.
Sales of Duracell products were well above those of the prior year and
profits increased substantially in the United States and all international
regions. The launch of Duracell Ultra and price increases contributed to
notably higher sales in the United States and Western Europe.
Braun sales were virtually unchanged, as significant growth in the United
States, and moderately higher sales in Western Europe were offset by the
strong dollar and weak business environment in Japan. Profits through six
months were up significantly, particularly in the United States and
Western Europe.
Toiletries sales were notably below prior year and profits were down
significantly. The sales shortfall was primarily due to the divestiture
of Jafra, as well as promotional timing in the United States of deodorant
and antiperspirant brands, and continued softness in White Rain.
Sales of stationery products were well below prior year and profits were
down significantly, primarily due to the financial crisis in Asia, where
stationery products have a strong market presence.
Sales of Oral-B products were modestly ahead of prior year, led by strong
volume growth of Advantage Control Grip in the United States. Profits
were up significantly, due to improved product mix and cost containment.
<PAGE>
PAGE 12
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS
Gross profit was
$2.68 billion, a decrease of $7 million, or less than 1%, from 1997.
Gross profit as a percentage of sales was 61.7%, equal to the same period
in 1997.
Selling, general and administrative expenses decreased by $99 million, or
6%. Combined advertising and sales promotion expenses decreased 4%
versus prior year. Spending on research and development increased 2%,
while other marketing and administrative expenses decreased 8%.
Profit from Operations was $1,029 million, up 10% from $937 million a
year earlier. Profit from operations increased well above prior year in
foreign operations and was modestly higher in the United States.
Net interest expense was lower, while net exchange losses were higher and
the effective tax rate was lower.
Net income of $640 million increased 12%, compared with $572 million in
1997. Diluted net income per common share of $.56 increased 12% over the
$.50 of a year earlier.
Financial Condition
Net cash provided by operating activities for the six months ended June
30, 1998, amounted to $281 million, compared with $468 million in the
same period last year. Receivables are a source of funds through six
months, but to a lesser degree than in 1997, due to the higher
receivables balance of December, 1996. Inventories showed more growth
than in the comparable 1997 period due to trade-initiated destocking of
older systems and Gillette MACH3 inventory build.
Other long-term liabilities have decreased substantially due to funding of
German pension plans. Net debt (total debt, net of associated swaps, less
cash and short-term investments) at June 30, 1998, amounted to $2.28
billion, compared to $1.87 billion at year end 1997. The Company's
current ratio at June 30, 1998, was 2.02, compared to 1.78 at December 31,
1997.
Jafra Cosmetics International was divested on April 30, 1998, the impact
on Profit from Operations and Net Income was not material.
<PAGE>
PAGE 13
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
The Company is subject, from time to time, to legal proceedings and
claims arising out of its business, which cover a wide range of matters,
including antitrust and trade regulation, product liability, contracts,
environmental issues, patent and trademark matters and taxes.
Management, after review and consultation with counsel, considers that
any liability from all of these legal proceedings and claims would not
materially affect the consolidated financial position, results of
operations or liquidity of the Company.
Item 5. Other Information
Forward-Looking Statements
From time to time, the Company may make statements which constitute or
contain "forward-looking" information as that term is defined in the
Private Securities Litigation Reform Act of 1995 (the "Act") or by the
Securities and Exchange Commission in its rules, regulations and
releases. The Company cautions investors that any such forward-looking
statements made by the Company are not guarantees of future performance
and that actual results may differ materially from those in the forward-
looking statements. The following are some of the factors that could
cause actual results to differ materially from estimates contained in the
Company's forward-looking statements: the pattern of the Company's
sales, including variations in sales volume within periods, which makes
forward-looking statements about sales and earnings difficult and may
result in variance of actual results from those contained in statements
made at any time prior to the period's close; vigorous competition within
the Company's product markets, including pricing and promotional,
advertising or other activities in order to preserve or gain market
share, the timing of which cannot be foreseen by the Company; the
Company's reliance on the development of new products and the inherent
risks associated with new product introductions, including uncertainty of
trade and customer acceptance and competitive reaction; the Company's
reliance on new systems implementation; the costs and effects of
unanticipated legal and administrative proceedings; the impacts of
unusual items resulting from ongoing evaluations of business strategies,
asset valuations and organizational structure; historically, almost two-
thirds of the Company's sales having been made outside the United States,
making forward-looking statements more difficult; the impact on sales or
earnings of fluctuations in exchange rates in one or more of the
Company's geographic markets; the impact of the year 2000 on the
Company's order, production, distribution and financial systems and the
systems of its suppliers and customers; and the possibility of one or
more of the global markets in which the Company competes being impacted
by variations in political, economic or other factors, such as currency
exchange rates, inflation rates, recessionary or expansive trends, tax
changes, legal and regulatory changes or other external factors over
which the Company has no control.
<PAGE>
PAGE 14
SIGNATURE
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
THE GILLETTE COMPANY
(Registrant)
CHARLES W. CRAMB
Charles W. Cramb
Senior Vice President-Finance,
Chief Financial Officer and
Principal Accounting Officer
July 24, 1998
<PAGE>
PAGE 15
EXHIBIT INDEX
For Quarterly Report on Form 10Q for the Quarterly Period Ended June 30,
1998
Exhibit
27 Financial Data Schedule
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
The data reported in this exhibit are based on unaudited statements but
include all adjustments which the company considers necessary for a fair
presentation of results for this period.
</LEGEND>
<CIK> 0000041499
<NAME> THE GILLETTE COMPANY
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-1998
<PERIOD-END> JUN-30-1998
<CASH> 76,000
<SECURITIES> 0
<RECEIVABLES> 2,418,000
<ALLOWANCES> 56,000
<INVENTORY> 1,823,000
<CURRENT-ASSETS> 4,830,000
<PP&E> 5,428,000
<DEPRECIATION> 2,217,000
<TOTAL-ASSETS> 11,081,000
<CURRENT-LIABILITIES> 2,390,000
<BONDS> 1,760,000
0
91,000
<COMMON> 1,356,000
<OTHER-SE> 3,866,000
<TOTAL-LIABILITY-AND-EQUITY> 11,081,000
<SALES> 4,350,000
<TOTAL-REVENUES> 4,350,000
<CGS> 1,665,000
<TOTAL-COSTS> 1,665,000
<OTHER-EXPENSES> 1,656,000
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 34,000
<INCOME-PRETAX> 989,000
<INCOME-TAX> 349,000
<INCOME-CONTINUING> 640,000
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 640,000
<EPS-PRIMARY> .57
<EPS-DILUTED> .56
</TABLE>
